REIN THERAPEUTICS INC (RNTX) Stock Balance Sheet
NASDAQ:RNTX - US00887A2042 - Common Stock
1.33 USD
-0.03 (-2.56%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.72M | 12.87M | 17.31M | 5.19M | 3.60M | |||
| Marketable Securities | N/A | N/A | 0.00 | 16.05M | 42.33M | |||
| Other Current Assets | 880.00K | 792.00K | 953.00K | 640.00K | 2.25M | |||
| Total Current Assets | 6.60M | 13.66M | 18.27M | 21.87M | 48.18M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.00K | 1.00K | 19.00K | 110.00K | 280.00K | |||
| Goodwill | 6.33M | 6.33M | 6.33M | N/A | N/A | |||
| Intangibles | 42.20M | 42.20M | 79.20M | N/A | N/A | |||
| Other Non-Current Assets | 2.35M | 2.00K | 2.19M | 20.00K | 20.00K | |||
| Total Non-Current Assets | 50.88M | 48.53M | 87.74M | 140.00K | 300.00K | |||
| TOTAL ASSETS | 57.48M | 62.19M | 106.01M | 22.01M | 48.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.67M | 4.84M | 3.19M | 1.66M | 3.30M | |||
| Accounts Payable | 6.03M | 911.00K | 1.19M | 1.72M | 1.21M | |||
| Total Current Liabilities | 7.69M | 5.75M | 4.38M | 3.38M | 4.51M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 1.77M | 1.77M | 3.33M | N/A | N/A | |||
| Other Non-Current Liabilities | 0.00 | 277.00K | N/A | 0.00 | 70.00K | |||
| Total Non-Current Liabilities | 1.77M | 2.05M | 3.33M | 0.00 | 70.00K | |||
| TOTAL LIABILITIES | 9.47M | 7.80M | 7.71M | 3.38M | 4.58M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -363.72M | -351.40M | -288.52M | -272.79M | -245.46M | |||
| Additional Paid In Capital | 366.67M | 360.70M | 295.38M | 291.37M | 289.28M | |||
| Common Shares | 45.11M | 45.11M | 91.50M | 90.00K | 90.00K | |||
| Other Shareholders' Equity | -44.00K | -18.00K | -63.00K | -50.00K | -10.00K | |||
| Shares Outstanding | 23.05M | 21.67M | 4.89M | 4.54M | 4.53M | |||
| Tangible Book Value per Share | -1.98 | -1.81 | -16.10 | 4.10 | 9.69 | |||
| Total Shareholders' Equity | 48.01M | 54.39M | 98.30M | 18.62M | 43.90M | |||
| TOTAL LIABILITIES AND EQUITY | 57.48M | 62.19M | 106.01M | 22.01M | 48.48M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.86 | 2.38 | 4.17 | 6.47 | 10.68 | |||
| Return On Assets (ROA) | -102.91% | -101.11% | -14.84% | -124.17% | -53.96% | |||
| Return On Equity (ROE) | -123.20% | -115.61% | -16.00% | -146.78% | -59.59% | |||
All data in USD , ROIC based on taxRate of 0.21